Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor

D L Andress1

  • 1Medical Service, Veterans Affairs Medical Center, Seattle 98108, USA.

Insights

Insulin-like growth factor (IGF)-binding protein-5 (IGFBP-5) binds to osteoblasts and activates a 420-kDa membrane protein receptor. This interaction stimulates serine/threonine kinase activity, suggesting a role in IGF-independent signaling.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Insulin-like growth factor (IGF)-binding protein-5 (IGFBP-5) interacts with osteoblasts.
  • A 420-kDa membrane protein was previously suggested as a potential IGFBP-5 signaling receptor.
  • IGFBP-5 binding to osteoblasts can be downregulated by IGFBP-5 itself.

Purpose of the Study:

  • To affinity-purify the 420-kDa membrane protein using an IGFBP-5 peptide.
  • To investigate the functional properties of the purified 420-kDa protein.
  • To explore the role of IGFBP-5 in receptor phosphorylation and kinase activation.

Main Methods:

  • Affinity purification of the 420-kDa membrane protein using IGFBP-5-(201-218) peptide.
  • In vitro kinase assays using [32P]ATP to assess autophosphorylation and substrate phosphorylation.
  • Incubation with intact IGFBP-5 and various IGFBP-5 fragments to study phosphorylation enhancement.

Main Results:

  • The 420-kDa membrane protein was successfully purified.
  • The purified protein exhibited autophosphorylation at serine residues.
  • IGFBP-5, IGFBP-5-(1-169), and IGFBP-5-(201-218) enhanced the serine phosphorylation of the 420-kDa protein.
  • The IGFBP-5 receptor phosphorylated casein on serine residues in the presence of [32P]ATP.

Conclusions:

  • IGFBP-5 stimulates the phosphorylation of its putative 420-kDa membrane receptor.
  • The data suggest that serine/threonine kinase activation is involved in mediating IGF-independent effects of IGFBP-5.
  • These findings identify a novel signaling pathway for IGFBP-5 in osteoblasts.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...